NeoRegen and Circio progress circular RNA research collaboration
Circio Holding and NeoRegen Biotech have signed a second Material Transfer Agreement (MTA) to advance their ongoing collaboration for the delivery of circular RNA (circRNA) expression-based therapeutics. The collaboration now is progressing to the in vivo preclinical stage following successful proof-of-concept (POC) results from… Read More